3rd Quarter - Report — CAPITOL PARTNERS, LLC for CMC PHARMA (2021)

Firm

CAPITOL PARTNERS, LLC

Client

CMC PHARMA

Income

$7,500

Expenses

—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Small Business SMB

innovations in medical countermeasures/research funding for vaccines

Lobbyist	Covered position, as disclosed
DORA J. PRUCE	—

Contacted: HOUSE OF REPRESENTATIVES; Defense Advanced Research Projects Agency (DARPA); SENATE; Small Business Administration (SBA); Defense Threat Reduction Agency (DTRA)

Science/Technology SCI

funding to support vaccine research/innovations in medical countermeasures

Lobbyist	Covered position, as disclosed
DORA J. PRUCE New	—

Contacted: Defense Advanced Research Projects Agency (DARPA); Small Business Administration (SBA); HOUSE OF REPRESENTATIVES; Defense Threat Reduction Agency (DTRA); SENATE

Defense DEF

supporting covid vaccine research and programs; defense funding to support innovations in medical countermeasures

Lobbyist	Covered position, as disclosed
DORA J. PRUCE	—

Contacted: Small Business Administration (SBA); HOUSE OF REPRESENTATIVES; SENATE; Defense Advanced Research Projects Agency (DARPA); Defense Threat Reduction Agency (DTRA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.